Zimvie Inc. ( (ZIMV) ) has released its Q1 earnings. Here is a breakdown of the information Zimvie Inc. presented to its investors.
ZimVie Inc., a global leader in the dental market, specializes in developing, manufacturing, and delivering comprehensive dental solutions, including implants and biomaterials, aimed at enhancing dental restoration procedures worldwide.
In its first quarter of 2025 financial report, ZimVie Inc. announced net sales of $112.0 million from continuing operations, alongside a net loss of $2.6 million, reflecting a significant improvement from the previous year’s loss. The company also reported an adjusted EBITDA of $17.6 million, indicating a positive trend in operational efficiency.
Key financial highlights from the report include a 5.2% decrease in net sales compared to the first quarter of 2024, with a net loss margin improvement from 9.7% to 2.3%. Adjusted net income rose by $5.2 million to $7.4 million, and adjusted diluted EPS reached $0.27. The company also provided a full-year guidance for 2025, projecting net sales between $445 million and $460 million, and adjusted EBITDA in the range of $65 million to $70 million.
Looking ahead, ZimVie Inc. remains focused on driving operational efficiency and profitability improvements. The management is optimistic about returning to top-line growth by continuing to innovate and educate within the dental industry, aiming to maintain its leading market position.